(Q73889210)

English

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group

scientific article published on 01 November 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

M D Goodman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Tarnoff

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Kain

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G J Slotman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

The American Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

174

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

527-531

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Another look at induction chemotherapy for organ preservation in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Continuous course radiation therapy and concurrent combination chemotherapy for squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Concurrent radiation therapy, 5-fluorouracil, and cisplatin for stage II, III, and IV, node-negative, squamous cell head and neck cancer. Results and surgical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil, both in continuous 96-hour infusion, in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

THE LEVEL OF CERVICAL LYMPH NODE METASTASES: THEIR PROGNOSTIC RELEVANCE AND RELATIONSHIP WITH HEAD AND NECK SQUAMOUS CARCINOMA PRIMARY SITES

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Lymph node prognostic factors in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Predicting factors for distant metastases in head and neck carcinomas: an analysis of 103 patients with locoregional control

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Growth Factor mRNA Expression in Human Head and Neck Malignant Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Significance of thrombocytosis in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Prognostic significance of thrombocytosis in patients with primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Plasma thromboxane A2 and prostacyclin concentrations in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Sedimentation rate and serum thymidine kinase activity: prognostic factors in squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Identifiers

10.1016/S0002-9610(97)00151-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73889210&oldid=2231621741"